BIT
CBAY

BlackRock Institutional Trust’s Cymabay Therapeutics CBAY Stock Holding History

BlackRock Institutional Trust’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$80K Hold
46,238
– – ﹤0.01% 3669
2016
Q3 		$90K Hold
46,238
– – ﹤0.01% 3707
2016
Q2 		$80K Hold
46,238
– – ﹤0.01% 3734
2016
Q1 		$62K Hold
46,238
– – ﹤0.01% 3773
2015
Q4 		$78K Hold
46,238
– – ﹤0.01% 3775
2015
Q3 		$90K Hold
46,238
– – ﹤0.01% 3742
2015
Q2 		$124K Buy
+46,238
New +$190K ﹤0.01% 3696

Other funds holding CBAY

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock Institutional Trust's CBAY Position: Q4 2016 in Review

BlackRock Institutional Trust held its Cymabay Therapeutics (CBAY) position steady in Q4 2016 at 46,238 shares worth $80K. The position accounts for ﹤0.01% of the portfolio, ranked #3669.

BlackRock Institutional Trust first reported a position in CBAY in Q2 2015 and has held it in 7 quarters since. The position peaked at $124K in Q2 2015. 27 funds tracked by Wall St. Rank hold CBAY as of Q4 2016.

  • BlackRock Institutional Trust held 46,238 shares of Cymabay Therapeutics worth $80K as of Q4 2016.
  • BlackRock Institutional Trust left its Cymabay Therapeutics share count unchanged in Q4 2016.
  • Cymabay Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3669 holding.
  • BlackRock Institutional Trust first reported a position in Cymabay Therapeutics in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Institutional Trust's Cymabay Therapeutics position peaked at $124K in Q2 2015.
  • 27 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.